
Inhibition of RANKL- and LPS-induced osteoclast differentiations by novel NF-κB inhibitor DTCM-glutarimide
Keywords: آکت; Osteoclastogenesis; DTCM-glutarimide; RANKL; LPS; Akt; NF-κB;